{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:02:09Z","timestamp":1788494529340,"version":"build-2803163510"},"reference-count":91,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.berh.2020.101563","type":"journal-article","created":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T16:10:54Z","timestamp":1593965454000},"page":"101563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical insights into Charcot foot"],"prefix":"10.1016","volume":"34","author":[{"given":"Brian M.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2020.101563_bib1","series-title":"Lectures on the localisation of cerebral and spinal diseases","author":"Charcot","year":"1883"},{"key":"10.1016\/j.berh.2020.101563_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40842-017-0041-4","article-title":"Physician knowledge of a rare foot condition - influence of diabetic patient population on self-described knowledge and treatment","volume":"3","author":"Schmidt","year":"2017","journal-title":"Clin Diabetes Endocrinol"},{"key":"10.1016\/j.berh.2020.101563_bib3","series-title":"Summary report Charcot workshop, co-sponsored by NIH's office of rare diseases","author":"Niddk","year":"2008"},{"issue":"3","key":"10.1016\/j.berh.2020.101563_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00005792-197205000-00006","article-title":"Neuro-arthropathy (Charcot joints) in diabetes mellitus","volume":"51","author":"Sinha","year":"1972","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.berh.2020.101563_bib5","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2337\/diacare.23.6.796","article-title":"Long-term follow-up in diabetic Charcot feet with spontaneous onset","volume":"23","author":"Fabrin","year":"2000","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.berh.2020.101563_bib6","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2337\/diacare.26.5.1435","article-title":"Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort","volume":"26","author":"Lavery","year":"2003","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.berh.2020.101563_bib7","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1464-5491.2005.01677.x","article-title":"The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture","volume":"22","author":"Chantelau","year":"2005","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.berh.2020.101563_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1464-5491.2010.03141.x","article-title":"The consequences of complacency: managing the effects of unrecognized Charcot feet","volume":"28","author":"Wukich","year":"2011","journal-title":"Diabet Med"},{"issue":"9","key":"10.1016\/j.berh.2020.101563_bib9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/1071100716649173","article-title":"Correlation of systemic inflammatory markers with radiographic stages of Charcot osteoarthropathy","volume":"37","author":"Hingsammer","year":"2016","journal-title":"Foot Ankle Int"},{"issue":"5","key":"10.1016\/j.berh.2020.101563_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7547\/1010437","article-title":"The Charcot foot in diabetes","volume":"101","author":"Rogers","year":"2011","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"4","key":"10.1016\/j.berh.2020.101563_bib11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.11622\/smedj.2016074","article-title":"Risk factors of diabetic foot Charcot arthropathy: a case-control study at a Malaysian tertiary care centre","volume":"57","author":"Fauzi","year":"2016","journal-title":"Singap Med J"},{"key":"10.1016\/j.berh.2020.101563_bib12","series-title":"Orthopaedic proceedings","article-title":"High rate of Charcot foot attacks early after simultaneous pancreas-kidney transplantation","year":"2009"},{"issue":"1","key":"10.1016\/j.berh.2020.101563_bib13","first-page":"31","article-title":"Risk factors of charcot neuroarthropathy development in patients with type 2 diabetes","volume":"122","author":"Nehring","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes \u2013 Off J German Soc Endocrinol Ger Diabet Assoc"},{"issue":"3","key":"10.1016\/j.berh.2020.101563_bib14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1590\/2359-3997000000042","article-title":"Risk factors for Charcot foot","volume":"59","author":"Nobrega","year":"2015","journal-title":"Archiv Endocrinol Metabol"},{"issue":"6","key":"10.1016\/j.berh.2020.101563_bib15","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1464-5491.2005.01510.x","article-title":"Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes","volume":"22","author":"Petrova","year":"2005","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.berh.2020.101563_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13047-019-0343-0","article-title":"Charcot arthropathy of the diabetic foot in a sub-Saharan tertiary hospital: a cross-sectional study","volume":"12","author":"Wanzou","year":"2019","journal-title":"J\u00a0Foot Ankle Res"},{"key":"10.1016\/j.berh.2020.101563_bib17","series-title":"National diabetes statistics report, 2017","author":"Control CfD Prevention","year":"2017"},{"issue":"5","key":"10.1016\/j.berh.2020.101563_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4239\/wjd.v2.i5.59","article-title":"Charcot osteoarthropathy in diabetes: a brief review with an emphasis on clinical practice","volume":"2","author":"Gouveri","year":"2011","journal-title":"World J Diabetes"},{"issue":"S4","key":"10.1016\/j.berh.2020.101563_bib19","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1017\/S0317167100040671","article-title":"Clinical testing in diabetic peripheral neuropathy","volume":"21","author":"Feldman","year":"1994","journal-title":"Can J Neurol Sci"},{"issue":"11","key":"10.1016\/j.berh.2020.101563_bib20","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.2337\/diacare.25.11.2048","article-title":"Validation of the Toronto clinical scoring system for diabetic polyneuropathy","volume":"25","author":"Bril","year":"2002","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.berh.2020.101563_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/2473011418774269","article-title":"An evidence-based introduction to Charcot foot Arthropathy","volume":"3","author":"Pinzur","year":"2018","journal-title":"Foot Ankle Orthop"},{"issue":"5","key":"10.1016\/j.berh.2020.101563_bib22","doi-asserted-by":"crossref","first-page":"816","DOI":"10.2337\/dc08-1695","article-title":"Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone","volume":"32","author":"Sohn","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.berh.2020.101563_bib23","series-title":"Charcot neuropathic osteoarthropathy and peripheral arterial disease","year":"2015"},{"issue":"4","key":"10.1016\/j.berh.2020.101563_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/j.jfas.2016.01.051","article-title":"Prevalence of peripheral arterial disease in patients with diabetic charcot neuroarthropathy","volume":"55","author":"Wukich","year":"2016","journal-title":"J\u00a0Foot Ankle Surg \u2013 Off Publ Am Coll foot Ankle Surg"},{"issue":"7","key":"10.1016\/j.berh.2020.101563_bib25","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2337\/dc10-2315","article-title":"Loss of RAGE defense: a cause of Charcot neuroarthropathy?","volume":"34","author":"Witzke","year":"2011","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.berh.2020.101563_bib26","doi-asserted-by":"crossref","first-page":"26627","DOI":"10.3402\/dfa.v6.26627","article-title":"A\u00a0literature-based guide to the conservative and surgical management of the acute Charcot foot and ankle","volume":"6","author":"Schade","year":"2015","journal-title":"Diabet Foot Ankle"},{"issue":"2","key":"10.1016\/j.berh.2020.101563_bib27","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.2337\/dc16-2204","article-title":"Plantar shear stress in individuals with a history of diabetic foot ulcer: an emerging predictive marker for foot ulceration","volume":"40","author":"Yavuz","year":"2017","journal-title":"Diabetes Care"},{"issue":"9502","key":"10.1016\/j.berh.2020.101563_bib28","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/S0140-6736(05)67029-8","article-title":"The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes","volume":"366","author":"Jeffcoate","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.berh.2020.101563_bib29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2337\/dc09-1141","article-title":"Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot","volume":"33","author":"Uccioli","year":"2010","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.berh.2020.101563_bib30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/17453674.2015.1033606","article-title":"Role of Wnt\/\u03b2-catenin and RANKL\/OPG in bone healing of diabetic Charcot arthropathy patients: a prospective study in 24 patients followed for 2 years","volume":"86","author":"Folestad","year":"2015","journal-title":"Acta Orthop"},{"issue":"4","key":"10.1016\/j.berh.2020.101563_bib31","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbrc.2012.06.015","article-title":"Receptor for advanced glycation end products inhibits proliferation in osteoblast through suppression of Wnt, PI3K and ERK signaling","volume":"423","author":"Li","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.berh.2020.101563_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/CRD.0b013e318244e57c","article-title":"Advanced glycation end products and diabetic cardiovascular disease","volume":"20","author":"Prasad","year":"2012","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.berh.2020.101563_bib33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fendo.2013.00068","article-title":"Diabetes alters activation and repression of pro-and anti-inflammatory signaling pathways in the vasculature","volume":"4","author":"Di Marco","year":"2013","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.berh.2020.101563_bib34","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1053\/j.jfas.2011.05.005","article-title":"Trabecular quality and cellular characteristics of normal, diabetic, and Charcot bone","volume":"50","author":"La Fontaine","year":"2011","journal-title":"J\u00a0Foot Ankle Surg"},{"issue":"2","key":"10.1016\/j.berh.2020.101563_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jemt.10121","article-title":"Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells","volume":"58","author":"Togari","year":"2002","journal-title":"Microsc Res Tech"},{"issue":"6","key":"10.1016\/j.berh.2020.101563_bib36","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/jor.20807","article-title":"Marked loss of sympathetic nerve fibers in chronic Charcot foot of diabetic origin compared to ankle joint osteoarthritis","volume":"27","author":"Koeck","year":"2009","journal-title":"J\u00a0Orthop Res"},{"issue":"1","key":"10.1016\/j.berh.2020.101563_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/2473011416S00162","article-title":"Distribution of neuropeptides in the synovium of charcot neuroarthropathy","volume":"1","author":"Schon","year":"2016","journal-title":"Foot Ankle Orthop"},{"issue":"5","key":"10.1016\/j.berh.2020.101563_bib38","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.jfas.2008.05.009","article-title":"Levels of endothelial nitric oxide synthase and calcitonin gene-related peptide in the Charcot foot: a pilot study","volume":"47","author":"La Fontaine","year":"2008","journal-title":"J\u00a0Foot Ankle Surg \u2013 Off Publ Am Coll foot Ankle Surg"},{"issue":"2","key":"10.1016\/j.berh.2020.101563_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jemt.10119","article-title":"Neuronal regulation of bone metabolism and anabolism: calcitonin gene-related peptide-, substance P-, and tyrosine hydroxylase-containing nerves and the bone","volume":"58","author":"Imai","year":"2002","journal-title":"Microsc Res Tech"},{"issue":"4","key":"10.1016\/j.berh.2020.101563_bib40","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0196-9781(00)00185-6","article-title":"Effects of CGRP on human osteoclast-like cell formation: a possible connection with the bone loss in neurological disorders?","volume":"21","author":"Akopian","year":"2000","journal-title":"Peptides."},{"issue":"1","key":"10.1016\/j.berh.2020.101563_bib41","doi-asserted-by":"crossref","first-page":"21117","DOI":"10.3402\/dfa.v4i0.21117","article-title":"An overview of the Charcot foot pathophysiology","volume":"4","author":"Kaynak","year":"2013","journal-title":"Diabet Foot Ankle"},{"issue":"1","key":"10.1016\/j.berh.2020.101563_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.niox.2009.04.002","article-title":"Nitric oxide enhances osteoclastogenesis possibly by mediating cell fusion","volume":"21","author":"Nilforoushan","year":"2009","journal-title":"Nitric Oxide \u2013 Biol Chem"},{"issue":"4","key":"10.1016\/j.berh.2020.101563_bib43","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.bbrc.2008.03.007","article-title":"Inhibition of osteocyte apoptosis by fluid flow is mediated by nitric oxide","volume":"369","author":"Tan","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.berh.2020.101563_bib44","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2337\/dc09-0243","article-title":"Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic charcot neuroarthropathy: a case-control study","volume":"32","author":"Pitocco","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.berh.2020.101563_bib45","first-page":"1","article-title":"Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy","volume":"28","author":"Korzon-Burakowska","year":"2011","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.berh.2020.101563_bib46","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.1780330316","article-title":"Rapidly progressive Charcot arthropathy following minor joint trauma in patients with diabetic neuropathy","volume":"33","author":"Slowman-Kovacs","year":"1990","journal-title":"Arthritis Rheum \u2013 Off J Am Col Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2020.101563_bib47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1096-9136(199705)14:5<357::AID-DIA341>3.0.CO;2-8","article-title":"The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic","volume":"14","author":"Armstrong","year":"1997","journal-title":"Diabet Med"},{"key":"10.1016\/j.berh.2020.101563_bib48","series-title":"Diabetic neuropathic osteoarthropathy : the Charcot foot. The high risk foot in diabetes mellitus","author":"Sanders","year":"1991"},{"issue":"2","key":"10.1016\/j.berh.2020.101563_bib49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/ptj\/77.2.169","article-title":"Infrared dermal thermometry for the high-risk diabetic foot","volume":"77","author":"Armstrong","year":"1997","journal-title":"Phys Ther"},{"issue":"2","key":"10.1016\/j.berh.2020.101563_bib50","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2337\/dc09-0950","article-title":"Role of quantitative bone scanning in the assessment of bone turnover in patients with Charcot foot","volume":"33","author":"Bem","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.berh.2020.101563_bib51","first-page":"22","article-title":"Describing normative foot temperatures in patients with diabetes-related peripheral neuropathy","volume":"14","author":"Schmidt","year":"2020","journal-title":"J\u00a0Diabet Sci Technol"},{"issue":"2","key":"10.1016\/j.berh.2020.101563_bib52","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.diabres.2011.12.029","article-title":"Charcot foot: skin temperature as a good clinical parameter for predicting disease outcome","volume":"96","author":"Moura-Neto","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.berh.2020.101563_bib53","doi-asserted-by":"crossref","first-page":"16450","DOI":"10.1038\/s41598-017-16365-7","article-title":"Circulating microparticles in acute diabetic Charcot foot exhibit a high content of inflammatory cytokines, and support monocyte-to-osteoclast cell induction","volume":"7","author":"Pasquier","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2020.101563_bib54","first-page":"1485","article-title":"Charcot joints","volume":"44","author":"Eichenholtz","year":"1962","journal-title":"J\u00a0Bone Joint Surg"},{"key":"10.1016\/j.berh.2020.101563_bib55","series-title":"The significance of the latent period which elapses between onset and radiographic appearances","author":"Brailsford","year":"1945"},{"issue":"3","key":"10.1016\/j.berh.2020.101563_bib56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/107110078000100304","article-title":"Radiographic measurements of the normal adult foot","volume":"1","author":"Steel","year":"1980","journal-title":"Foot Ankle"},{"issue":"13","key":"10.1016\/j.berh.2020.101563_bib57","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.2106\/JBJS.L.00250","article-title":"Progression of foot deformity in Charcot neuropathic osteoarthropathy","volume":"95","author":"Hastings","year":"2013","journal-title":"J\u00a0Bone Jt Surg Am Vol"},{"issue":"11","key":"10.1016\/j.berh.2020.101563_bib58","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1177\/1071100714547218","article-title":"Radiographic analysis of diabetic midfoot charcot neuroarthropathy with and without midfoot ulceration","volume":"35","author":"Wukich","year":"2014","journal-title":"Foot Ankle Int"},{"issue":"3","key":"10.1016\/j.berh.2020.101563_bib59","first-page":"723","article-title":"Use of MR imaging in diagnosing diabetes-related pedal osteomyelitis","volume":"30","author":"Donovan","year":"2010","journal-title":"Radiographics \u2013 Rev Publ Radiol Soc N Am"},{"issue":"1","key":"10.1016\/j.berh.2020.101563_bib60","doi-asserted-by":"crossref","first-page":"18754","DOI":"10.3402\/dfa.v3i0.18754","article-title":"Current challenges in imaging of the diabetic foot","volume":"3","author":"Eser Sanverdi","year":"2012","journal-title":"Diabet Foot Ankle"},{"key":"10.1016\/j.berh.2020.101563_bib61","series-title":"IWGDF guideline on offloading foot ulcers in persons with diabetes","author":"Bus","year":"2019"},{"issue":"6","key":"10.1016\/j.berh.2020.101563_bib62","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2337\/diacare.24.6.1019","article-title":"Off-loading the diabetic foot wound: a randomized clinical trial","volume":"24","author":"Armstrong","year":"2001","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.berh.2020.101563_bib63","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/dmrr.2386","article-title":"Comparison of the clinical effectiveness of different off-loading devices for the treatment of neuropathic foot ulcers in patients with diabetes: a systematic review and meta-analysis","volume":"29","author":"Morona","year":"2013","journal-title":"Diabet Metabol Res Rev"},{"issue":"1","key":"10.1016\/j.berh.2020.101563_bib64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/03093640701318672","article-title":"Wound healing: total contact cast vs. custom-made temporary footwear for patients with diabetic foot ulceration","volume":"32","author":"Van De Weg","year":"2008","journal-title":"Prosthet Orthot Int"},{"issue":"12","key":"10.1016\/j.berh.2020.101563_bib65","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.2337\/diacare.23.12.1746","article-title":"Effectiveness and safety of a nonremovable fiberglass off-bearing cast versus a therapeutic shoe in the treatment of neuropathic foot ulcers: a randomized study","volume":"23","author":"Caravaggi","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.berh.2020.101563_bib66","doi-asserted-by":"crossref","DOI":"10.1177\/1534734619861571","article-title":"Influence of patient setting and dedicated limb salvage efforts on outcomes in charcot-related foot ulcer","author":"Schmidt","year":"2019","journal-title":"Int J Low Extrem Wounds"},{"issue":"6","key":"10.1016\/j.berh.2020.101563_bib67","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7547\/8750-7315-104.6.555","article-title":"The management of diabetic foot ulcers through optimal off-loading: building consensus guidelines and practical recommendations to improve outcomes","volume":"104","author":"Snyder","year":"2014","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"4","key":"10.1016\/j.berh.2020.101563_bib68","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2106\/JBJS.F.01523","article-title":"Charcot arthropathy and immobilization in a weight-bearing total contact cast","volume":"90","author":"de Souza","year":"2008","journal-title":"JBJS"},{"key":"10.1016\/j.berh.2020.101563_bib69","first-page":"205","article-title":"Plantar pressures with total contact casting","volume":"32","author":"Wertsch","year":"1995","journal-title":"J\u00a0Rehabil Res Dev"},{"issue":"3","key":"10.1016\/j.berh.2020.101563_bib70","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2337\/diacare.28.3.551","article-title":"Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial","volume":"28","author":"Armstrong","year":"2005","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.berh.2020.101563_bib71","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2337\/dc15-2373","article-title":"Role and determinants of adherence to off-loading in diabetic foot ulcer healing: a prospective investigation","volume":"39","author":"Crews","year":"2016","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.berh.2020.101563_bib72","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/107110070602700503","article-title":"Treatment of Eichenholtz stage I Charcot foot arthropathy with a weightbearing total contact cast","volume":"27","author":"Pinzur","year":"2006","journal-title":"Foot Ankle Int"},{"issue":"8","key":"10.1016\/j.berh.2020.101563_bib73","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/107110070402500806","article-title":"Surgical versus accommodative treatment for Charcot arthropathy of the midfoot","volume":"25","author":"Pinzur","year":"2004","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.berh.2020.101563_bib74","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00003086-200506000-00026","article-title":"How effective is intensive nonoperative initial treatment of patients with diabetes and Charcot arthropathy of the feet?","volume":"435","author":"Saltzman","year":"2005","journal-title":"Clin Orthop Relat Res"},{"issue":"24","key":"10.1016\/j.berh.2020.101563_bib75","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2020.101563_bib76","article-title":"Charcot neuropathic arthropathy of the foot: a literature review and single-center experience","volume":"2016","author":"Kucera","year":"2016","journal-title":"J\u00a0Diabet Res"},{"issue":"11","key":"10.1016\/j.berh.2020.101563_bib77","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/s001250100008","article-title":"Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial","volume":"44","author":"Jude","year":"2001","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.berh.2020.101563_bib78","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/diacare.28.5.1214","article-title":"Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial","volume":"28","author":"Pitocco","year":"2005","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.berh.2020.101563_bib79","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2337\/dc11-0396","article-title":"The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy: a pilot randomized controlled trial","volume":"34","author":"Pakarinen","year":"2011","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.berh.2020.101563_bib80","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.2337\/dc06-0376","article-title":"Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial","volume":"29","author":"Bem","year":"2006","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.berh.2020.101563_bib81","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.2337\/dc17-1517","article-title":"Effect of single dose of RANKL antibody treatment on acute Charcot neuro-osteoarthropathy of the foot","volume":"41","author":"Busch-Westbroek","year":"2018","journal-title":"Diabetes Care"},{"issue":"296","key":"10.1016\/j.berh.2020.101563_bib82","first-page":"21","article-title":"Exostectomy for symptomatic bony prominences in diabetic charcot feet","author":"Brodsky","year":"1993","journal-title":"Clin Orthop Relat Res"},{"issue":"5","key":"10.1016\/j.berh.2020.101563_bib83","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1067-2516(00)80045-9","article-title":"Ostectomy for diabetic neuroarthropathy involving the midfoot","volume":"39","author":"Catanzariti","year":"2000","journal-title":"J\u00a0Foot Ankle Surg"},{"issue":"2","key":"10.1016\/j.berh.2020.101563_bib84","doi-asserted-by":"crossref","first-page":"53","DOI":"10.12968\/jowc.2008.17.2.28178","article-title":"Exostectomy for chronic midfoot plantar ulcer in Charcot deformity","volume":"17","author":"Laurinaviciene","year":"2008","journal-title":"J\u00a0Wound Care"},{"issue":"2","key":"10.1016\/j.berh.2020.101563_bib85","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3113\/FAI.2012.0113","article-title":"Surgical management of Charcot neuroarthropathy of the foot and ankle: a systematic review","volume":"33","author":"Lowery","year":"2012","journal-title":"Foot Ankle Int"},{"issue":"5","key":"10.1016\/j.berh.2020.101563_bib86","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1067-2516(97)80037-3","article-title":"Neuropathic ulcerations plantar to the lateral column in patients with Charcot foot deformity: a flexible approach to limb salvage","volume":"36","author":"Rosenblum","year":"1997","journal-title":"J\u00a0Foot Ankle Surg"},{"issue":"6","key":"10.1016\/j.berh.2020.101563_bib87","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00000658-199206000-00009","article-title":"Management of diabetic midfoot ulcers","volume":"215","author":"Wieman","year":"1992","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.berh.2020.101563_bib88","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/107110070502600910","article-title":"Reliability of AOFAS diabetic foot questionnaire in Charcot arthropathy: stability, internal consistency, and measurable difference","volume":"26","author":"Dhawan","year":"2005","journal-title":"Foot Ankle Int"},{"issue":"7","key":"10.1016\/j.berh.2020.101563_bib89","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/1071100717701233","article-title":"Functional impairment of patients undergoing surgical correction for Charcot foot arthropathy","volume":"38","author":"Kroin","year":"2017","journal-title":"Foot Ankle Int"},{"issue":"10","key":"10.1016\/j.berh.2020.101563_bib90","first-page":"492","article-title":"Health-related quality of life in patients with Charcot foot","volume":"32","author":"Pinzur","year":"2003","journal-title":"Am J Orthoped (Belle Mead, NJ)"},{"issue":"3","key":"10.1016\/j.berh.2020.101563_bib91","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1071100713517097","article-title":"Self-reported quality of life in patients with diabetes: a comparison of patients with and without Charcot neuroarthropathy","volume":"35","author":"Raspovic","year":"2014","journal-title":"Foot Ankle Int"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694220300802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694220300802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:19:45Z","timestamp":1761499185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694220300802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1521694220300802"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2020.101563","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical insights into Charcot foot","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2020.101563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101563"}}